Moore Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$2.13M	–	528
2024 Q2	$2.13M	Buy	+20,000	New	+$2.2M	0.05%	267
2023 Q4	–	Sell	-6,100	Closed	-$790K	–	508
2023 Q3	$790K	Sell	6,100 -5,900	-49%	-$786K	0.02%	312
2023 Q2	$1.49M	Buy	12,000 +9,000	+300%	+$1.21M	0.04%	280
2023 Q1	$439K	Buy	+3,000	New	+$444K	0.01%	327
2022 Q3	–	Sell	-45,829	Closed	-$7.15M	–	727
2022 Q2	$7.15M	Sell	45,829 -114,771	-71%	-$17.7M	0.22%	126
2022 Q1	$25M	Buy	+160,600	New	+$23.3M	0.82%	26
2021 Q1	–	Sell	-169,449	Closed	-$28M	–	739
2020 Q4	$28M	Buy	169,449 +86,995	+106%	+$13M	0.48%	47
2020 Q3	$11.8M	Buy	+82,454	New	+$10.2M	0.32%	92
2016 Q1	–	Sell	-35,000	Closed	-$4.92M	–	291
2015 Q4	$4.92M	Buy	+35,000	New	+$4.85M	0.17%	143